HomeInsightsPE

Sun Pharmaceuticals Industries Ltd PE Ratio

Sun Pharmaceuticals Industries Ltd PE Ratio

stocks purchased

₹ 13.2 Cr

Volume transacted

stocks purchased

69.4 K

stocks traded

Last Updated time: 13 Oct 9.00 AM

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

PE

43.3

Last updated: 13 Oct 9.00 AM

Key Highlights

  • The P/E Ratio of Sun Pharmaceuticals Industries Ltd is 43.3 as of 13 Oct 9.00 AM.
  • The P/E Ratio of Sun Pharmaceuticals Industries Ltd changed from 43.1 on March 2019 to 40.6 on March 2024 . This represents a CAGR of -0.99% over 6 years. .
  • The Latest Trading Price of Sun Pharmaceuticals Industries Ltd is ₹ 1901 as of 11 Oct 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.2. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Sun Pharmaceuticals Industries Ltd

No data available

Company Fundamentals for Sun Pharmaceuticals Industries Ltd

No data available

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

PRICE

1901.95

14.55 (0.77%)

stock direction

Last updated: 11 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Sun Pharmaceuticals Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
11 Oct 20241901.95
10 Oct 20241887.4
09 Oct 20241931.2
08 Oct 20241916.85
07 Oct 20241904.8
04 Oct 20241910.5
03 Oct 20241913.6
01 Oct 20241919.4
30 Sep 20241926.3
27 Sep 20241948.9

SWOT Analysis Of Sun Pharmaceuticals Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sun Pharmaceuticals Industries Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Sun Pharmaceuticals Industries Ltd434,56,341
Divis Laboratories Ltd971,63,028
Cipla Ltd291,28,827
Torrent Pharmaceuticals Ltd701,18,373
Mankind Pharma Ltd571,11,956
Dr Reddys Laboratories Ltd191,10,160

Key Valuation Metric of Sun Pharmaceuticals Industries Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Revenue of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in crore

Historical Dividend Payout of Sun Pharmaceuticals Industries Ltd

No data available

* All values are in %

About Sun Pharmaceuticals Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Sun Pharmaceuticals Industries Ltd News Hub

News

Sun Pharmaceuticals Industries to hold board meeting

Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...

Read more

09 Oct 202417:30

News

Sun Pharma inks global licensing agreement with Philogen

Sun Pharmaceutical Industries and Philogen S.p.A (Philogen) today announced that they have...

Read more

01 Oct 202410:34

News

Sun Pharma inks exclusive pact with Philogen for commercializing anti-cancer drug Fibromun

Philogen is an Italian-Swiss company active in the biotechnology sector, specialized in th...

Read more

01 Oct 202410:34

News

Sun Pharma, Moebius Medical gets USFDA FTD to MM-II

MM-II is a novel non-opioid product that uses a proprietary suspension of large, empty, mu...

Read more

06 Sep 202412:55

News

Sun Pharma and Israel-based Moebius Medical announce USFDA grant of Fast Track designation to MM-II

Sun Pharmaceutical Industries and Israel-based Moebius Medical announced that the U.S. Foo...

Read more

06 Sep 202413:01

News

Sun Pharma hits record high on launching skin infection drug, Starizo

Starizo (Tedizolid Phosphate) is a novel, oxazolidinone-class antibacterial, used to treat...

Read more

23 Aug 202414:54

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Sun Pharmaceuticals Industries Ltd

What is the current PE Ratio of Sun Pharmaceuticals Industries Ltd?

The Current PE Ratio of Sun Pharmaceuticals Industries Ltd is 43.28 as on 13 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 13 Oct 2024.

What was the PE Ratio of Sun Pharmaceuticals Industries Ltd last year?

The PE Ratio of Sun Pharmaceuticals Industries Ltd was 27.83 last year, now the PE ratio is 43.28, showing a year-on-year growth of 55.5%.

What does the PE Ratio of Sun Pharmaceuticals Industries Ltd indicate about its stock?

The PE Ratio of Sun Pharmaceuticals Industries Ltd is 43.28. This ratio indicates that investors are willing to pay 43.28 times the earnings per share for each share of Sun Pharmaceuticals Industries Ltd.

What is the PE Ratio Growth of Sun Pharmaceuticals Industries Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sun Pharmaceuticals Industries Ltd grew by 55.5% whereas, the EPS ratio grew by 6.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*